ViThera is developing innovative drugs for use in veterinary medicine.

ViThera is conducting early proof-of concept studies in collaboration with university researchers to prove the ability of EnLact™ strains to protect poultry from Salmonella infection.  This technology confers protection from Salmonella infection without use of antibiotics.  Chickens are treated with EnLact™ strains early in life to confer protection against Salmonella typhimurium infection, and reduce risk to consumers.